CD38-Expressing NK Cells: Emerging Contributors to Immune Regulation
Overview
This report discusses the role of CD38-expressing NK cells in various diseases, highlighting their opposing effects on immune regulation in conditions such as rheumatoid arthritis and colorectal cancer.
Background
CD38 is a transmembrane protein that plays a crucial role in immune regulation by degrading NAD+. The presence of CD38-expressing NK cells has been linked to several diseases, including rheumatoid arthritis and colorectal cancer.
Data Highlights
No numerical data or trial data was provided in the source material.
Key Findings
Increased proportions of CD38+ NK cells are found in patients with rheumatoid arthritis, producing high levels of IFN-γ.
CD38+ NK cells in colorectal cancer patients produce low levels of IFN-γ and high levels of TGF-β, promoting Treg differentiation.
CD38+CD16+ NK cells suppress Treg differentiation, while CD38+CD16- NK cells promote it, indicating opposing regulatory effects.
HSPA1B expression is decreased in CD38+ NK cells from colorectal cancer patients but increased in those from rheumatoid arthritis patients.
CD38+ NK cells were not detected in CD38-KO tumor-bearing mice, suggesting their role in tumor growth regulation.
Clinical Implications
The findings indicate that CD38+ NK cells are involved in the immune landscape of diseases like rheumatoid arthritis and colorectal cancer.
Conclusion
CD38-expressing NK cells exhibit diverse roles in immune regulation across different diseases.
